Diatheva | 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022 | Lisbnona
With great enthusiasm, DIATHEVA participates in the 32nd European [...]
With great enthusiasm, DIATHEVA participates in the 32nd European [...]
In 16.6% of spontaneous abortion cases L. monocytogenes is the [...]
DIATHEVA presented a new product in pipeline "scFv 2G8" [...]
Diatheva’s pipeline antibody-based therapies is designated to address significant unmet [...]
A recent paper published in the prestigious scientific journal Clinical [...]